- In September 2024, researchers from the University of Chicago's Pritzker School of Molecular Engineering and UCLA's Samueli School of Engineering unveiled a novel diagnostic system that integrates a field-effect transistor with a paper-based analytical cartridge. This hybrid biosensor, enhanced by machine learning algorithms, demonstrated over 97% accuracy in measuring cholesterol levels in serum samples. The innovation combines the high sensitivity of transistor-based detection with the affordability and simplicity of paper-based tests, potentially revolutionizing at-home diagnostics for various health conditions
- In September 2024, ARCpoint Inc. expanded its collaboration with MD Care Group by enhancing its Application Programming Interface (API) to allow telehealth practitioners to order diagnostic tests directly through ARCpoint's MyARCpointLabs platform. This integration streamlines the process for virtual healthcare providers to facilitate diagnostic testing, thereby improving patient access to timely and convenient health assessments
- In August 2024, Qiagen and AstraZeneca announced the expansion of their partnership to develop companion diagnostics for chronic diseases beyond oncology. Utilizing Qiagen's QIAstat-Dx platform, the collaboration aims to create genotyping assays that can identify patients suitable for targeted therapies during routine clinical evaluations, marking a significant step towards personalized medicine in chronic disease management
- In June 2024, BioAI, a biotech firm specializing in artificial intelligence applications, partnered with Genomic Testing Cooperative to develop AI-driven digital pathology solutions. The collaboration focuses on creating genomic biomarker screening algorithms and assays, enhancing clinical research and diagnostic applications through advanced computational tools
- In June 2024, the World Health Organization (WHO) joined forces with ASEAN member states during a regional consultative meeting in Thailand to enhance access to quality diagnostic testing. The initiative aimed to support the development and implementation of National Essential Diagnostics Lists (NEDLs), ensuring that essential diagnostic tests are available and accessible across Southeast Asia
